Clinical Trials Directory

Trials / Completed

CompletedNCT06898697

Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia

Midazolam or Fentanyl as Adjuvants to Epidural Bupivacaine Plus Dexamethasone for Analgesia After Lumbar Spine Fixation: A Randomized Clinical Study

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
100 (actual)
Sponsor
Zagazig University · Other Government
Sex
All
Age
21 Years – 64 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to compare better postoperative analgesia after lumbar spine Fixation using either epidural bupivacaine with midazolam or fentanyl with the combination of dexamethasone.

Detailed description

After being informed about the study and potential risks. A computer-generated randomization table will randomize all patients giving written consent into 2 groups, each containing 51 patients. In the Fentanyl Group :.Patients will receive 10 ml of bupivacaine 0. 25 % plus 100µg fentanyl in 2ml plus 2ml (8mg) dexamethasone.In Midazolam Group: Patients will receive 10 ml of bupivacaine 0.25 % plus 2mg midazolam in 2ml plus 2 ml (8mg) dexamethasone

Conditions

Interventions

TypeNameDescription
DRUGEpidural fentanylFentanyl will be injected in the epidural space by the surgeon one or two levels above the surgical site.
DRUGepidural midazolammidazolam will be injected in the epidural space by the surgeon one or two levels above the surgical site.

Timeline

Start date
2025-04-01
Primary completion
2025-12-01
Completion
2025-12-01
First posted
2025-03-27
Last updated
2026-01-21

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT06898697. Inclusion in this directory is not an endorsement.